PRAS40 suppresses atherogenesis through inhibition of mTORC1-dependent pro-inflammatory signaling in endothelial cells. - Zhang KS; Schecker J; Krull A; Riechert E; Jürgensen L; Kamuf-Schenk V; Burghaus J; Kiper L; Cao Ho T; Wöltje K; Stangl V; Katus HA; et al. (Scientific reports, 2019)